Acumen is forging a new path towards safe and effective treatments for Alzheimer’s disease and other neurodegenerative diseases through our focus on the biology of toxic amyloid-beta oligomers.

Pharmaceutical

Acumen Pharmaceuticals

Daniel O’Connell

Victoria Baird

Alex Braun

Kristen Elkins

Julie Bockenstette

Amber Dilley

Kasey Spencer

David Potter

Derek Meisner

Matthew Zuga

Russell Barton

Eric Siemers

Jerry Moore

The leadership team at Acumen Pharmaceuticals has a wide range of experience in the pharmaceutical industry. The team has experience with companies such as Ammonett Pharma LLC, Direct Spinal Therapeutics Inc, Naurex Inc., and Functional Neuromodulation. The team also has experience in educational institutions such as the Indiana University School of Medicine and Brown University.

Leadership Team

Board of Directors

CEO and Executive Team

Leadership Team

About

Team members

Other teams at Acumen Pharmaceuticals

Board of Directors

CEO and Executive Team